A design space is established to: Response:

Question

Options

• ALimit creativity in product development
• BProvide a framework within which changes can be made without further regulatory approval
• CEncourage a trial-and-error approach to manufacturing
• DSimplify documentation requirements

• A
  7% (2)
• B
  75% (21)
• C
  4% (1)
• D
  14% (4)

Explanation

A design space (a concept from ICH Q8 pharmaceutical guidelines) establishes the multidimensional combination of input variables and process parameters within which operation is expected to assure product quality - and critically, operating within the design space is not considered a change, meaning companies can adjust parameters freely without triggering additional regulatory submissions. This makes B correct: it provides a pre-approved framework for operational flexibility.

Why the distractors are wrong:

• A is the opposite of intent - design space expands legitimate flexibility, not creativity constraints.
• C is wrong because design space is built on scientific understanding, not trial-and-error; it reflects deliberate risk assessment.
• D is a distractor because design space typically adds documentation burden (it must be justified and approved), not reduces it.

Memory tip: Think of design space as a "pre-approved playground" - regulators review and approve the boundaries upfront, so anything you do inside the playground doesn't require asking permission again.

No community discussion yet for this question.